ALY-101

N/A

Report date: 2025/03/07 11:49:07
NME

Base Information

Drug NameALY-101
Drug Alias NameALY-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTyrosine-protein kinase JAK1 modulatorsRNA interference
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsAlopecia AreataEczemaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlys Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlys Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAlopecia AreataEczemaDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A